ATE413166T1 - Transdermales pflaster enthaltend einen schmelzpunktsenkenden hilfsstoff - Google Patents

Transdermales pflaster enthaltend einen schmelzpunktsenkenden hilfsstoff

Info

Publication number
ATE413166T1
ATE413166T1 AT05077630T AT05077630T ATE413166T1 AT E413166 T1 ATE413166 T1 AT E413166T1 AT 05077630 T AT05077630 T AT 05077630T AT 05077630 T AT05077630 T AT 05077630T AT E413166 T1 ATE413166 T1 AT E413166T1
Authority
AT
Austria
Prior art keywords
melting point
drug
plaster containing
transdermal plaster
excipient
Prior art date
Application number
AT05077630T
Other languages
English (en)
Inventor
Toshiro Yamaguchi
Mitsuru Kuribayashi
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE413166T1 publication Critical patent/ATE413166T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05077630T 2004-11-22 2005-11-21 Transdermales pflaster enthaltend einen schmelzpunktsenkenden hilfsstoff ATE413166T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004336871 2004-11-22

Publications (1)

Publication Number Publication Date
ATE413166T1 true ATE413166T1 (de) 2008-11-15

Family

ID=35809740

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05077630T ATE413166T1 (de) 2004-11-22 2005-11-21 Transdermales pflaster enthaltend einen schmelzpunktsenkenden hilfsstoff

Country Status (5)

Country Link
US (1) US7744918B2 (de)
EP (1) EP1661560B1 (de)
AT (1) ATE413166T1 (de)
DE (1) DE602005010812D1 (de)
ES (1) ES2317138T3 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
CA2445086C (en) 2001-05-01 2008-04-08 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions
US20050113510A1 (en) * 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
EP1390084B1 (de) 2001-05-01 2011-03-23 A.V. Topchiev Institute of Petrochemical Synthesis Zweiphasige, wasserabsorbierende bioadhäsive zusammenstezung
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
KR20070007299A (ko) 2004-01-30 2007-01-15 코리움 인터네셔널, 인크. 활성제의 전달을 위한 급속 용해 필름
JPWO2005117886A1 (ja) * 2004-06-01 2008-04-03 久光製薬株式会社 貼付剤
US20070134310A1 (en) * 2005-09-23 2007-06-14 Nedberge Diane E Transdermal risperidone delivery system
RU2445959C2 (ru) * 2006-06-09 2012-03-27 ДАЙНИППОН СУМИТОМО ФАРМА Ко., ЛТД. Новый лейкопластырный препарат
KR100835074B1 (ko) * 2006-09-27 2008-06-03 조선대학교산학협력단 멜록시캄 경피 흡수제 조성물 및 그의 제조 방법
JP5110712B2 (ja) * 2006-12-01 2012-12-26 日東電工株式会社 ドネペジル含有貼付製剤の経時的な変色を抑制する方法
RU2445953C2 (ru) * 2006-12-01 2012-03-27 Нитто Денко Корпорейшн Стабилизированная адгезивная композиция, содержащая донепезил
EP1985290A1 (de) * 2007-04-26 2008-10-29 Sansho Cosme Inc. Auf die Haut aufzutragendes Medikament, Verfahren zu seiner Auftragung auf der Haut und Verfahren zu seiner Herstellung
JP5333972B2 (ja) * 2007-11-22 2013-11-06 株式会社 メドレックス 脂肪酸系イオン液体を有効成分とする外用剤組成物
WO2009110351A1 (ja) * 2008-03-03 2009-09-11 久光製薬株式会社 経皮吸収製剤
RU2481826C2 (ru) * 2008-05-30 2013-05-20 Нитто Денко Корпорейшн Содержащий донепезил адгезивный препарат и упаковка для него
CN102046171B (zh) * 2008-05-30 2013-06-19 日东电工株式会社 经皮吸收制剂
EP2311498A4 (de) * 2008-08-05 2013-07-24 Medrx Co Ltd Externes präparat mit einem fettsäuresalz oder einem benzoesäuresalz aus einer basischen pharmakologischen wirkstoffkomponente sowie verfahren zu seiner herstellung
CA2751884C (en) * 2009-01-14 2018-09-25 Corium International, Inc. Transdermal administration of tamsulosin
JP5664871B2 (ja) 2009-06-19 2015-02-04 株式会社 メドレックス アリピプラゾールと有機酸を有効成分とする外用剤組成物
US20100178307A1 (en) * 2010-01-13 2010-07-15 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
CN103501770B (zh) * 2011-04-18 2015-04-29 久光制药株式会社 贴附剂的制造方法及贴附剂
HUE046004T2 (hu) * 2011-04-25 2020-01-28 Shan Dong Luye Pharm Co Ltd Risperidon nyújtott hatóanyagleadású mikroszféra készítmény
WO2014052837A1 (en) 2012-09-28 2014-04-03 Delpor, Inc. Device and methods for sustained release of antipsychotic medications
GB201317718D0 (en) * 2013-10-07 2013-11-20 Buzzz Pharmaceuticals Ltd Novel formulation
EP3062819B1 (de) 2013-11-03 2021-12-22 The Regents of The University of California Ionische flüssigkeiten zur transdermalen arzneimittelverabreichung
IL260290B2 (en) 2015-12-30 2023-11-01 Corium Inc Systems and methods for long-term percutaneous administration
US11541018B2 (en) 2016-06-23 2023-01-03 Corium, Llc Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
JP7153010B2 (ja) 2016-07-27 2022-10-13 コリウム， インコーポレイテッド 塩薬物のｉｎ ｓｉｔｕでの塩から中性の薬物変換による、低溶解度または不安定非イオン化中性薬物の経皮配合物および送達方法
MX2019001104A (es) 2016-07-27 2019-10-02 Corium Int Inc Sistemas de suministro transdermico de memantina.
EP3503927B1 (de) 2016-08-29 2025-02-19 The Regents of the University of California Topische formulierungen auf basis von ionischen spezies zur hautbehandlung
US10828265B2 (en) * 2016-12-09 2020-11-10 The Regents Of The University Of California Formulations of propranolol and analogs as an amorphous melt or ionic liquid for transdermal drug delivery
CA3047354A1 (en) 2016-12-20 2018-06-28 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
RU2762896C2 (ru) 2016-12-20 2021-12-23 Лтс Ломанн Терапи-Систем Аг Трансдермальная терапевтическая система, содержащая азенапин
KR102279552B1 (ko) * 2016-12-28 2021-07-19 히사미쓰 세이야꾸 가부시키가이샤 부토르파놀 함유 첩부제
TWI783984B (zh) 2017-04-05 2022-11-21 日商帝國製藥股份有限公司 含有利培酮之貼附劑
CN110545816B (zh) * 2017-04-25 2023-04-11 久光制药株式会社 贴附剂
EP3644973B1 (de) 2017-06-26 2021-03-24 LTS LOHMANN Therapie-Systeme AG Transdermales therapeutisches system mit hybridem asenapin- und silikonacrylpolymer
CA3086163A1 (en) 2017-12-20 2019-06-27 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
KR102024996B1 (ko) * 2017-12-27 2019-09-25 동아에스티 주식회사 도네페질을 함유하는 치매 치료용 경피흡수제제
CN112533593A (zh) 2018-06-20 2021-03-19 罗曼治疗系统股份公司 含有阿塞那平的透皮治疗系统
CN110958876B (zh) 2018-06-20 2020-12-18 罗曼治疗系统股份公司 含有阿塞那平的透皮治疗系统
US11559525B2 (en) 2019-04-26 2023-01-24 Sumitomo Pharma Co., Ltd. Therapeutic drug for dyskinesia
US10758535B1 (en) 2019-04-26 2020-09-01 Sumitomo Dainippon Pharma Co., Ltd. Therapeutic drug for dyskinesia
TW202140017A (zh) * 2020-02-19 2021-11-01 日商大日本住友製藥股份有限公司 經皮吸收製劑
MX2023002422A (es) 2020-08-31 2023-03-22 Sumitomo Pharma Co Ltd Farmaco terapeutico para complicaciones motoras en enfermedad de parkinson.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
EP0387751B1 (de) * 1989-03-15 1994-06-08 Nitto Denko Corporation Arzneimittel enthaltendes Heftpflaster
JP2944010B2 (ja) 1992-06-25 1999-08-30 オークマ株式会社 ヒートシンク
JP3908795B2 (ja) * 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
TW592729B (en) 1995-04-06 2004-06-21 Janssen Pharmaceutica Nv Rate-controlled transdermal administration of risperidone
TW411277B (en) * 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
FR2758263B1 (fr) 1997-01-16 1999-12-17 Oreal Utilisation d'un antagoniste ou d'un agoniste de serotonine specifiques respectivement du recepteur 5ht2 et 5ht1d dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue
JP4205778B2 (ja) 1998-04-17 2009-01-07 久光製薬株式会社 貼付製剤
CA2366838A1 (en) 1999-03-18 2000-09-21 Gina Guadagno A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications
DE60045153D1 (de) 1999-04-13 2010-12-09 Hisamitsu Pharmaceutical Co Zubereitungen zur perkutanen absorption
DK1201232T3 (da) 1999-07-27 2007-08-13 Hisamitsu Pharmaceutical Co Plastre til ydre anvendelse
US20030124176A1 (en) 1999-12-16 2003-07-03 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US20030104041A1 (en) 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
JP2005082512A (ja) 2003-09-05 2005-03-31 Medorekkusu:Kk イオン性の薬物の経皮吸収性を高めた外用剤
US20070134310A1 (en) * 2005-09-23 2007-06-14 Nedberge Diane E Transdermal risperidone delivery system

Also Published As

Publication number Publication date
EP1661560A1 (de) 2006-05-31
DE602005010812D1 (de) 2008-12-18
EP1661560B1 (de) 2008-11-05
US7744918B2 (en) 2010-06-29
ES2317138T3 (es) 2009-04-16
US20060110434A1 (en) 2006-05-25

Similar Documents

Publication Publication Date Title
ATE413166T1 (de) Transdermales pflaster enthaltend einen schmelzpunktsenkenden hilfsstoff
EP1928537A4 (de) Vorrichtungen für die transkutane abgabe von vakzinen und transdermale abgabe von arzneimitteln und ihre verwendungen
DK1853250T3 (da) Kombinationer og måder til indgivelse af terapeutiske midler og kombinationsterapi
ATE468332T1 (de) Phenyl-(4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin- - yi)aminderivate
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
SE0401342D0 (sv) Therapeutic compounds
HUS1500018I1 (hu) A Bruton-féle tirozin-kináz inhibitorai
UY28923A1 (es) Compuestos terapéuticos: piridina como estructura base
EA200901155A1 (ru) Модуляторы фармакокинетических свойств терапевтических препаратов (варианты) и их использование в терапии
EA200900155A1 (ru) Модуляторы фармакокинетических свойств лекарственных средств
CY1112478T1 (el) Ενωσεις κιναζολινονης ως αντικαρκινικοι παραγοντες
DE602005011653D1 (de) Medizinprodukt mit gewebeabhängiger arzneimittelelution
MX2009006007A (es) Profarmacos y metodos para hacer y usar los mismos.
DE60336664D1 (de) Nichtnukleosidische reverse-transkriptase-hemmer
SE0401971D0 (sv) Piperidne derivatives
BRPI0413427A (pt) derivados de piridilpirrol ativos como inibidores da cinase
NO20064792L (no) Anvendelse av rotigotin til behandling og forbinding av Parkinsons pluss syndrom.
MXPA06014599A (es) Uso de meloxicam en medicina veterinaria para el tratamiento de enfermedades dolorosas inflamatorias.
IL192181A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
MX2007004248A (es) Derivados heterociclicos de bisarilurea sustituidos como inhibidores de cinasa.
DK1973540T3 (da) Anvendelse af benzokondenserede heterocycliske sulfamidderivater til behandling af smerte
CR8603A (es) Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
ATE400257T1 (de) Stabile pharmazeutische zusammensetzung mit linezolid form iv
PL1765310T3 (pl) Mieszanina do podawania przezskórnego nisko- i wysokocząsteczkowych związków
EA200901062A1 (ru) Использование ингибиторов растворимой эпоксидгидролазы для предотвращения и лечения метаболического синдрома и соответствующих расстройств

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties